Heightened cholesterol 25-hydroxylase expression in aged lung during Streptococcus pneumoniae

David G Thomas1,2, Jianjun Yang1, Soo Jung Cho1,2

  • 1Department of Medicine, Pulmonary and Critical Care, Weill Cornell Medicine, New York, NY, United States.

Frontiers in Aging
|December 24, 2024
PubMed
Abstract

Insights

Cholesterol 25-hydroxylase (Ch25h) impacts aged alveolar macrophages during Streptococcus pneumoniae infection. Reducing Ch25h improves bacterial clearance and immune responses in aging lungs.

Area of Science:

  • Immunology
  • Cell Biology
  • Aging Research

Background:

  • Alveolar macrophages (AM) are crucial for lung immunity against Streptococcus pneumoniae.
  • Altered lipid metabolism in AM can lead to inflammation and impaired function.
  • Aging affects immune cell function, increasing susceptibility to infections.

Purpose of the Study:

  • To investigate the role of cholesterol 25-hydroxylase (Ch25h) in aged AM during S. pneumoniae infection.
  • To determine if modulating Ch25h affects AM responses and bacterial clearance in aging lungs.

Main Methods:

  • Utilized in vitro and in vivo murine models of S. pneumoniae infection.
  • Employed Ch25h-specific siRNA to reduce enzyme expression in aged macrophages and lungs.
  • Assessed AM cholesterol metabolism, lipid droplet formation, phagocytic receptor expression, and bacterial clearance.

Main Results:

  • Aging altered cholesterol metabolism and increased lipid droplets in AM.
  • Ch25h inhibition in vitro enhanced S. pneumoniae clearance and phagocytic receptor expression.
  • In vivo Ch25h reduction improved clinical outcomes and bacterial clearance in aged mice.

Conclusions:

  • Cholesterol 25-hydroxylase (Ch25h) is a key regulator of aged AM function during S. pneumoniae infection.
  • Targeting Ch25h represents a potential therapeutic strategy to enhance immune responses in aging lungs.